Cargando…
Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727283/ https://www.ncbi.nlm.nih.gov/pubmed/34845317 http://dx.doi.org/10.1038/s41375-021-01355-6 |
| _version_ | 1784626489045549056 |
|---|---|
| author | García-Guerrero, Estefanía Götz, Ralph Doose, Sören Sauer, Markus Rodríguez-Gil, Alfonso Nerreter, Thomas Kortüm, K. Martin Pérez-Simón, José A. Einsele, Hermann Hudecek, Michael Danhof, Sophia |
| author_facet | García-Guerrero, Estefanía Götz, Ralph Doose, Sören Sauer, Markus Rodríguez-Gil, Alfonso Nerreter, Thomas Kortüm, K. Martin Pérez-Simón, José A. Einsele, Hermann Hudecek, Michael Danhof, Sophia |
| author_sort | García-Guerrero, Estefanía |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8727283 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87272832022-01-18 Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab García-Guerrero, Estefanía Götz, Ralph Doose, Sören Sauer, Markus Rodríguez-Gil, Alfonso Nerreter, Thomas Kortüm, K. Martin Pérez-Simón, José A. Einsele, Hermann Hudecek, Michael Danhof, Sophia Leukemia Correction Nature Publishing Group UK 2021-11-29 2022 /pmc/articles/PMC8727283/ /pubmed/34845317 http://dx.doi.org/10.1038/s41375-021-01355-6 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction García-Guerrero, Estefanía Götz, Ralph Doose, Sören Sauer, Markus Rodríguez-Gil, Alfonso Nerreter, Thomas Kortüm, K. Martin Pérez-Simón, José A. Einsele, Hermann Hudecek, Michael Danhof, Sophia Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
| title | Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
| title_full | Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
| title_fullStr | Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
| title_full_unstemmed | Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
| title_short | Publisher Correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab |
| title_sort | publisher correction: upregulation of cd38 expression on multiple myeloma cells by novel hdac6 inhibitors is a class effect and augments the efficacy of daratumumab |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727283/ https://www.ncbi.nlm.nih.gov/pubmed/34845317 http://dx.doi.org/10.1038/s41375-021-01355-6 |
| work_keys_str_mv | AT garciaguerreroestefania publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT gotzralph publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT doosesoren publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT sauermarkus publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT rodriguezgilalfonso publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT nerreterthomas publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT kortumkmartin publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT perezsimonjosea publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT einselehermann publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT hudecekmichael publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab AT danhofsophia publishercorrectionupregulationofcd38expressiononmultiplemyelomacellsbynovelhdac6inhibitorsisaclasseffectandaugmentstheefficacyofdaratumumab |